A 62-year-old woman with acute decompensated heart failure (ADHF) presents with pulmonary oedema, elevated JVP, and a BNP of 850 pg/mL. Regarding acute management of ADHF, all of the following statements are correct EXCEPT:

Question

Accepted Answer

D. Inotropes (dobutamine, milrinone) should be initiated early in all patients with reduced cardiac output to improve contractility. ## Acute Decompensated Heart Failure: Management Principles **Key Point:** Inotropes are NOT first-line agents in ADHF and should be reserved for cardiogenic shock or hypotension refractory to other measures. Early and indiscriminate use of inotropes increases mortality risk. ### First-Line Approach to ADHF ```mermaid flowchart TD A[Acute Decompensated HF
Pulmonary oedema + elevated JVP]:::outcome --> B{Haemodynamic status?}:::decision B -->|Euvolemic or congested
SBP > 90| C[Loop diuretics IV]:::action B -->|Hypotensive
SBP < 90| D[Vasopressor support]:::urgent C --> E{Symptom relief?}:::decision E -->|Yes| F[Continue diuretics
+ vasodilators if SBP permits]:::action E -->|No| G[Add vasodilator
or consider inotrope]:::action D --> H[Inotrope + vasopressor
for cardiogenic shock]:::urgent C --> I[Oxygen/NIV if
SpO2 < 90%]:::action ``` ### Role of Inotropes in ADHF | Scenario | Inotrope Use | Evidence | |---|---|---| | Acute pulmonary oedema, SBP > 90 mmHg | **NOT indicated** | Increases mortality; no symptom benefit over diuretics + vasodilators | | Cardiogenic shock (SBP < 90 + end-organ hypoperfusion) | **Indicated** | Bridge to mechanical support or recovery | | Low cardiac output + hypotension refractory to fluids | **Consider** | Dobutamine, milrinone as temporizing measure | | Acute MI with HF + hypotension | **Indicated** | Short-term use; aim for revascularization | **High-Yield:** The OPTIMIZE-HF and ESCAPE trials demonstrated that routine inotrope use in ADHF worsens outcomes. Inotropes increase heart rate, myocardial oxygen demand, and arrhythmia risk. Reserve them for shock states only. ### Mnemonic for ADHF Management Priorities **LOAD:** - **L** — Loop diuretics (first-line for congestion) - **O** — Oxygen / NIV (if hypoxic or respiratory distress) - **A** — ACE-I / Vasodilators (afterload reduction) - **D** — Dobutamine / inotropes (only if shock or severe hypotension) **Clinical Pearl:** In euvolemic or hypertensive ADHF, aggressive diuresis + vasodilation (nitroprusside, nitroglycerin) often resolves pulmonary oedema without inotropes. Inotropes should be a last resort, not a reflex first-line choice. **Warning:** Do not confuse "low cardiac output" with "cardiogenic shock." Low cardiac output alone (without hypotension or end-organ hypoperfusion) does not mandate inotropes. Many patients improve with diuretics and vasodilators alone.

Answer

A. Vasodilators (nitroprusside, nitroglycerin) reduce preload and afterload and improve symptoms in acute decompensation

Answer

B. Oxygen therapy and non-invasive ventilation (CPAP/BiPAP) are indicated when SpO₂ < 90% or respiratory distress is present

Answer

C. Diuretics (loop diuretics preferred) are the first-line agents for symptom relief in acute pulmonary oedema

A 62-year-old woman with acute decompensated heart failure (ADHF) presents with pulmonary oedema, elevated JVP, and a BNP of 850 pg/mL. Regarding acute management of ADHF, all of the following statements are correct EXCEPT:

Explanation

Acute Decompensated Heart Failure: Management Principles

First-Line Approach to ADHF

Role of Inotropes in ADHF

Mnemonic for ADHF Management Priorities

Practice similar questions

Join our NEET PG community

Scenario	Inotrope Use	Evidence
Acute pulmonary oedema, SBP > 90 mmHg	NOT indicated	Increases mortality; no symptom benefit over diuretics + vasodilators
Cardiogenic shock (SBP < 90 + end-organ hypoperfusion)	Indicated	Bridge to mechanical support or recovery
Low cardiac output + hypotension refractory to fluids	Consider	Dobutamine, milrinone as temporizing measure
Acute MI with HF + hypotension	Indicated	Short-term use; aim for revascularization